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Abstract
Background: The content of resveratrol is relatively high in Polygonum cuspidatum Sieb. et Zucc., and the resveratrol has the effect of blood vessel
dilating, microcirculation improving, platelet aggregation inhibiting and anti-cancer. The objective of this paper was to study the effect of
resveratrol on lipid metabolism in hyperlipidemia mice.
Materials and Methods: Through the establishment of an experimental mouse model of hyperlipidemia, the effect of resveratrol on change in total
cholesterol (TC), triglyceride (TG), high density lipoprotein cholesterol (HDL-c), and low-density lipoprotein cholesterol (LDL-c) levels in mouse
serum were determined.
Results: Resveratrol group can apparently reduce TC, TG, LDL-c and AI of hyperlipidemic mice in a dose effect manner.
Conclusion: We concluded that resveratrol can effectively reduce blood lipid levels of hyperlipidemic mice.
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Introduction
Resveratrol is a polyphenolic compound widespread in liliaceous, polygonaceous, leguminous plants, as well as grape skins, peanuts, and
a variety of medicinal plants. Its content is relatively high in Polygonum cuspidatum Sieb. et Zucc, a Chinese medicinal plant (Tyler, 1997; Jang et
al., 1997). Modern pharmacological studies have revealed the apparent pharmacological effects of resveratrol on the cardio-cerebrovascular
system, which has the blood vessel dilating, microcirculation improving, platelet aggregation inhibiting, anti-cancer, and anti-oxidant functions
(Fauconneau et al., 1997; Wnag et al., 2002; Liang et al., 1996; Xu et al., 2006; Li et al., 2009; Hyun et al 2004) . Previous studies explored the
lipid-lowering effect of resveratrol by treating mice with relatively high doses of resveratrol. In this study however, mice fed with a high fat diet
were treated with relatively low doses of resveratrol in order to observe the effects of resveratrol on their serum and liver lipid levels.
Materials and methods
Instruments and reagents
Resveratrol was extracted from Polygonum cuspidatum Sieb. et Zucc. identified by Professor Jiang Hehua from Qinghai University, and
the number is 2012-1001-05. During the experiment, the resveratrol was prepared to the suspensions of desired concentrations with distilled water.
Serum total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C)
kits were purchased from the BioSino Bio-technology & Science Inc., Beijing. Optical microscope, ECOM-F6124 semi-automatic biochemical
analyzer, high-speed tabletop centrifuge were also used.
Experimental animals
50 KM Mice, male (provided by the China Medical University), weighing 18-22 g, were fed ad libitum before the experiment. All experimental
procedures were approved by the Animal Research Ethics Committee of Shanxi Medical College University.
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Preparation of high-fat diet
The formula of high-fat diet was 1% cholesterol, 0.3% sodium cholate, 10% lard, and 88.7% basal feed.
Grouping and processing
The mice were randomly divided into five groups, i.e., a basic control group and four experimental groups (n = 10). All mice were
adaptively fed for 4 days ad libitum; temperature was controlled between 18-22℃. After adaptation, the high-fat group was fed with a high fat
diet for 4 weeks, then 0.5 mL of venous blood was collected from the inner canthus, serum was separated, and TC level was determined. The mice
were randomly divided into the high-fat group, resveratrol low-, medium- and high-dose groups according to the TC level. The basic control
group was fed a normal diet, and the high-fat group was continued to be fed with a high fat diet. The resveratrol treatment groups (low-, medium-
and high-dose groups) were intragastrically administered with 10, 20, and 40 mg/kg of resveratrol, respectively, and the basic control group and
the high-fat control group were given an equal volume of 0.5% sodium carboxymethyl cellulose solution. Feeding was continued for 6
consecutive weeks.
Test indices
Before killing, the animals were fasted for 12 h. Blood was collected from the eyeballs and serum was separated. Then, the animals were
killed, and livers were removed quickly and placed in a -70℃ refrigerator for later use. Serum indices: serum total cholesterol (TC), triglyceride
(TG), high-density lipoprotein cholesterol (HDL-c), and low-density lipoprotein cholesterol (LDL-c) levels were determined in strict accordance
with the kit instructions.
Statistical processing
Analysis of variance on experimental data was conducted using SPSS13 software. Test criterion α = 0.05. 
Results
Effect of resveratrol on body weight of hyperlipidemic model mice
There were no statistically significant differences in changes in body weight of the mice in each group before and after the experiment
(Table 1).
Table 1: Effect of resveratrol on body weight of hyperlipidemic mice (x
—
±s，n=10)
Group Dose (mg / kg) Body weight before experiment Body weight after experiment Amount of change
Basic control group 42.2±2.3 50.3±3.2 8.1±1.8
High-fat
Control group
42.5±3.1 50.9±3.5 8.4±0.9
10 43.2±3.4 52.3±4.5 9.1±2.3
20 42.7±2.5 49.4±4.6 6.7±2.8Resveratrol group
40 41.9±3.6 49.8±3.9 7.9±2.4
Effect of resveratrol on pathological change of liver in mice
Macroscopically, the livers of mice in the high-fat group were greasy, yellowish, with prominent facets; the edges were not smooth, and
grainy. The severity of hepatic steatosis in mice of the high-fat group was higher than that of each resveratrol treatment group. As can be seen
from Figure 1, the pathological sections of mouse livers show that the liver cells of mice in each experimental group were basically normal,
without occurrence of inflammatory cell infiltration, and fat vacuoles were present in only a small number of liver cells.
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Effect of resveratrol on lipid levels in mice
Compared with the basic control group, serum TC, LDL-C levels significantly increased in the high-fat group. TC levels of each
resveratrol treatment group were relatively low compared with the high-fat group, as shown in Figure 2 and Figure 3.
Normal control group High-fat group High-fat + resveratrol group
Figure 1: Pathological sections of livers of mice in each experimental group
Figure 2: Changes in lipid levels (TC, TG) in mice of each group
Figure 3: Changes in lipid levels (LDL-C, HDL-C) in mice of each group
Discussion
Hyperlipidemia is crucial for the induction of atherosclerosis and cardio-cerebrovascular diseases. Clinically, arteriosclerosis index (AI)
and TG level are often used as important criteria for the diagnosis of coronary artery disease. Plasma LDL combines with the proteoglycans in the
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arterial wall to produce insoluble precipitate, stimulating the proliferation of fibrous tissue, and thus causes the atherosclerotic plaque. Serum total
cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-c), and low-density lipoprotein cholesterol (LDL-c) are commonly
used indices, reflecting the body’s lipid metabolism. Polygonum cuspidatum Sieb. et Zucc, Radix Polygoni Multiflori and other Chinese
medicines rich in resveratrol have long been used in folk medicine for the treatment and prevention of hyperlipidemia and arteriosclerosis. Studies
have found that resveratrol can lower the liver lipid levels in rats, and reduce triglyceride synthesis in mouse liver (Garcia-Garcia et al., 1999;
Gronbaek et al., 2000; Doeherty et al., 1999).
In this experiment, mouse model of hyperlipidemia has been successfully established using a high-fat diet. Compared with the normal
control group, serum TG, TC levels, as well as TG level in liver tissue were significantly increased in mice of the model group. The resveratrol
group can significantly reduce the TC, TG, LDL-c and AI in hyperlipidemic mice in a dose effect manner. This may be due to the phenolic
hydroxyls contained in resveratrol, through oxidation. Cholesterol is suppressed and unsaturated fatty acids are oxidized. Platelet aggregation is
suppressed, accumulation of cholesterol and fat in the blood is prevented, and peripheral blood circulation is improved, thus exerting the
hyperlipidemia preventing and atherosclerosis inhibiting effects.
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